fludarabine has been researched along with African Lymphoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Green, S; Schultz, L | 1 |
| Almazi, JG; Christopherson, RI; Crossett, B; Kohnke, PL; Mactier, S | 1 |
| Amadori, S; Bruno, A; Buccisano, F; Cox, MC; Degan, M; Del Poeta, G; Del Principe, MI; Gattei, V; Marini, R; Maurillo, L; Panetta, P; Suppo, G; Venditti, A | 1 |
| Gadre, SA; Ge, Y; Lockhart, LH; Northup, JK; Velagaleti, GV | 1 |
| Christopherson, RI; Henrich, S | 1 |
| Banerji, V; Gibson, SB; Hu, X; Johnston, JB; Mendoza, FJ; Sun, J | 1 |
| Schilling, PJ | 1 |
1 review(s) available for fludarabine and African Lymphoma
| Article | Year |
|---|---|
Rational Alternatives to Fludarabine and Cyclophosphamide-Based Pre-CAR Lymphodepleting Regimens in the Pediatric and Young Adult B-ALL Setting.
Topics: Bendamustine Hydrochloride; Burkitt Lymphoma; Child; Clofarabine; Cyclophosphamide; Humans; Immunotherapy, Adoptive; Receptors, Antigen, T-Cell; Receptors, Chimeric Antigen; Young Adult | 2023 |
6 other study(ies) available for fludarabine and African Lymphoma
| Article | Year |
|---|---|
Fludarabine and cladribine induce changes in surface proteins on human B-lymphoid cell lines involved with apoptosis, cell survival, and antitumor immunity.
Topics: Antigens, CD; Apoptosis; B-Lymphocytes; Burkitt Lymphoma; Cell Adhesion; Cell Line; Cell Line, Tumor; Cell Survival; Cladribine; Drug Resistance, Neoplasm; Flow Cytometry; Glycoproteins; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Membrane Proteins; Reproducibility of Results; Signal Transduction; Up-Regulation; Vidarabine | 2012 |
Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia.
Topics: ADP-ribosyl Cyclase 1; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Burkitt Lymphoma; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Humans; Immunoglobulin Heavy Chains; Immunoglobulin Variable Region; Immunophenotyping; In Situ Hybridization, Fluorescence; Interphase; Life Tables; Male; Middle Aged; Neoplasm Proteins; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Solubility; Tumor Suppressor Protein p53; Vidarabine; ZAP-70 Protein-Tyrosine Kinase | 2004 |
Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Burkitt Lymphoma; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Chromosomes, Human, Pair 8; Chromosomes, Human, X; Clone Cells; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Female; Genes, myc; Humans; Karyotyping; Lymph Nodes; Lymphoma, AIDS-Related; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Mutagenesis, Insertional; Pleural Effusion, Malignant; Prednisone; Rituximab; Translocation, Genetic; Trisomy; Vidarabine; Vincristine | 2007 |
Multiple forms of nuclear p53 formed in human Raji and MEC1 cells treated with fludarabine.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Burkitt Lymphoma; Cell Line, Tumor; DNA Damage; Drug Resistance, Neoplasm; Genes, p53; Humans; Isoelectric Point; Leukemia, Lymphocytic, Chronic, B-Cell; Molecular Weight; Mutation; Neoplasm Proteins; Peptide Fragments; Peptide Hydrolases; Phosphorylation; Protein Processing, Post-Translational; Protein Structure, Tertiary; Tumor Suppressor Protein p53; Vidarabine | 2008 |
Lysophosphatidic acid (LPA) induces the expression of VEGF leading to protection against apoptosis in B-cell derived malignancies.
Topics: Apoptosis; Burkitt Lymphoma; Cell Line, Tumor; Gene Expression; Humans; JNK Mitogen-Activated Protein Kinases; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoproliferative Disorders; Lysophospholipids; Multiple Myeloma; Mutagens; NF-kappa B; RNA, Messenger; Vascular Endothelial Growth Factor A; Vidarabine | 2008 |
Two views of the immunologic effects of fludarabine.
Topics: Antineoplastic Agents; Burkitt Lymphoma; CD4-Positive T-Lymphocytes; Humans; Immunologic Deficiency Syndromes; Leukemia, Lymphocytic, Chronic, B-Cell; T-Lymphocytes, Regulatory; Vidarabine | 1991 |